Evidence map›Paper›PMID 42006463›Full record

ArticleChemical science2026

A (poly)Pro tip for preserving native disulfide connectivity during thiol-maleimide bioconjugation of disulfide-rich peptides.

Lylia Azzoug, Ana Novak, Hervé Meudal, Jean-Baptiste Madinier, Stéphane Charpentier, Karine Loth, Séverine Morisset-Lopez, Carlo Pifferi, Vincent Aucagne

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lylia AzzougCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.
Ana NovakCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.
Hervé MeudalCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.
Jean-Baptiste MadinierCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.
Stéphane CharpentierCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.
Karine LothCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.
Séverine Morisset-LopezCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.
Carlo PifferiCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.ORCID https://orcid.org/0000-0003-0861-1378
Vincent AucagneCentre de Biophysique Moléculaire, CNRS UPR 4301 Rue Charles Sadron 45071 Orléans France carlo.pifferi@cnrs-orleans.fr vincent.aucagne@cnrs-orleans.fr.ORCID https://orcid.org/0000-0002-2647-0188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generation of specific antibodies against peptides by immunization requires their covalent conjugation to protein carriers to override their inherently weak immunogenicity. The vast majority of bioconjugation approaches to achieve peptide-protein constructs rely on thiol-maleimide chemistry and capitalize on a wide array of commercial maleimide-functionalized protein carriers. Disulfide-rich peptides (DRPs) possess a rigid, constrained structure that makes them ideal for designing synthetic mimics of protein regions/domains. For bioconjugation purposes, the introduction of a single spare thiol moiety into a linear peptide antigen is straightforward, while DRPs' disulfide bonds are prone to intramolecular thiophilic attack by the reactive thiolate. This unintended reactivity competes with the desired Michael addition to the maleimide moiety, ultimately disrupting the native disulfide bridging framework. As a result, DRP's tertiary structure will be altered, affording an immunogen that is a poor mimic of the native target. Although a few studies have explored the late-stage introduction of thiol-containing cross-linkers into DRP antigens for their conjugation onto protein carriers, the stability of DRPs' disulfide pattern in the presence of an extra thiol has never been examined. In this study, we systematically evaluated the influence of different spacers in "DRP-spacer-thiol" constructs under thiol-maleimide reaction conditions. Our results highlight how both linker length and flexibility are key to maintaining DRP disulfides unaltered, providing a general approach to achieve DRP bioconjugation by thiol-maleimide chemistry. We have applied our approach to a small DRP predicted to closely mimic a surface-accessible epitope of the full LINGO-1 protein and obtained a very specific antibody response upon immunization; the resulting polyclonal IgG was able to selectively bind the full-length protein in a cellular context, with stringent selectivity across its four homologs.

Identifiers

PMID42006463
PMCPMC13085933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.